1. Home
  2. TECH vs KRYS Comparison

TECH vs KRYS Comparison

Compare TECH & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$43.55

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$308.98

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
KRYS
Founded
1976
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
7.8B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
TECH
KRYS
Price
$43.55
$308.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
11
Target Price
$71.82
$297.60
AVG Volume (30 Days)
2.8M
276.0K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
0.62%
N/A
EPS Growth
N/A
128.00
EPS
0.81
1.83
Revenue
$1,219,635,000.00
$389,130,000.00
Revenue This Year
$2.49
$38.74
Revenue Next Year
$6.40
$32.53
P/E Ratio
$55.27
$172.44
Revenue Growth
5.23
33.94
52 Week Low
$44.12
$123.03
52 Week High
$72.16
$319.48

Technical Indicators

Market Signals
Indicator
TECH
KRYS
Relative Strength Index (RSI) 32.35 65.82
Support Level N/A $253.89
Resistance Level $58.41 N/A
Average True Range (ATR) 3.19 12.66
MACD -1.08 3.09
Stochastic Oscillator 1.31 82.09

Price Performance

Historical Comparison
TECH
KRYS

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: